ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplimab in Patients With Resectable CSCC"
By
ecancer
FEATURING
Neil Gross
By
ecancer
FEATURING
Neil Gross
Login to view comments.
Click here to Login
